Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-1/Smad Pathway and Epithelial to Mesenchymal Transition

被引:16
|
作者
Meng, Lihong [1 ]
Zhang, Xiaomei [2 ]
Wang, Hong [3 ,4 ]
Dong, Huan [1 ]
Gu, Xiaofeng [1 ]
Yu, Xiaolin [1 ]
Liu, Yushan [1 ]
机构
[1] Beijing Univ Chinese Med, 11 North 3rd Ring Rd, Beijing 100029, Peoples R China
[2] Beijing Univ Chinese Med, Dongfang Hosp, Dept Resp Med, 6 1st Dist Fangxingyuan, Beijing 100078, Peoples R China
[3] Shunyi Hosp, Beijing Chinese Med Hosp, 5 Zhanqian East St, Beijing 101300, Peoples R China
[4] Capital Med Univ, Beijing Chinese Med Hosp, Art Museum, 23 Houjie St, Beijing 100010, Peoples R China
关键词
MYOFIBROBLAST; ACTIVATION; MECHANISMS; RECEPTOR;
D O I
10.1155/2019/2710509
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-1/Smad signal pathway and epithelial to mesenchymal transition (EMT). Methods. 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-1, TRI, TRII, Smad3, Smad7, -SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. Results. TGF-1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I were significantly increased (p <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group (p <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-1, CTGF, hydroxyproline contents, and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p <0.01 or p <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group (p <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant. Conclusion. These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGF β1/Smad-Mediated Epithelial-to-Mesenchymal Transition
    Zhou, Xiao-Ming
    Wang, Gui-Liang
    Wang, Xiao-Bo
    Liu, Li
    Zhang, Qin
    Yin, Yan
    Wang, Qiu-Yue
    Kang, Jian
    Hou, Gang
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [12] The compound artemisinin-hydroxychloroquine ameliorates bleomycin-induced pulmonary fibrosis in rats by inhibiting TGF-81/ Smad2/3 signaling pathway
    Wang, Zhaojia
    Liu, Min
    Ai, Ying
    Zheng, Shaoqin
    Chen, Yingyi
    Du, Hujun
    Yuan, Shijia
    Guo, Xueying
    Yuan, Yueming
    Li, Guoming
    Song, Jianping
    Deng, Changsheng
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 83
  • [13] Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF- β 1 signaling pathway
    Li, Shimeng
    Liu, Zhichao
    Jiao, Xiaodan
    Gu, Jinying
    Liu, Zhigang
    Meng, Lingxin
    Li, Wenqi
    Zhang, Tiantian
    Liu, Jing
    Chai, Dan
    Liu, Jiaai
    Yang, Zhongyi
    Liu, Yuming
    Jiao, Ran
    Li, Xiaohe
    Zhou, Honggang
    Zhang, Yanping
    BIOCHEMICAL PHARMACOLOGY, 2024, 225
  • [14] Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway
    Chen, Shanshan
    Wei, Yuli
    Li, Shimeng
    Miao, Yang
    Gu, Jinying
    Cui, Yunyao
    Liu, Zhichao
    Liang, Jingjing
    Wei, Luqing
    Li, Xiaohe
    Zhou, Honggang
    Yang, Cheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [15] NecroX-5 ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3-mediated epithelial–mesenchymal transition
    Li Min
    Zhang Shu-Li
    Yuan Feng
    Hu Han
    Li Shao-Jun
    Tong Sheng-Xiong
    Tian Jia-Yu
    Fang Xiang-Zhi
    Feng Dan
    Respiratory Research, 23
  • [16] Licoricesaponin G2 ameliorates bleomycin-induced pulmonary fibrosis via targeting TNF-α signaling pathway and inhibiting the epithelial-mesenchymal transition
    Ma, Jing
    Ding, Lu
    Zang, Xiaoyu
    Wei, Ruonan
    Yang, Yingying
    Zhang, Wei
    Su, Hang
    Li, Xueyan
    Li, Min
    Sun, Jun
    Zhang, Zepeng
    Wang, Zeyu
    Zhao, Daqing
    Li, Xiangyan
    Zhao, Linhua
    Tong, Xiaolin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [17] Low-molecular-weight fucoidan attenuates bleomycin-induced pulmonary fibrosis: possible role in inhibiting TGF-β1-induced epithelial-mesenchymal transition through ERK pathway
    Wang, Lu
    Zhang, Pan
    Li, Xinpeng
    Zhang, Yi
    Zhan, Qingyuan
    Wang, Chen
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (04): : 2590 - 2602
  • [18] Pachymic acid ameliorates bleomycin-induced pulmonary fibrosis through inhibiting endoplasmic reticulum stress in rats
    Li, Lin
    Jin, Rong-Jie
    Ji, Lu
    ENVIRONMENTAL TOXICOLOGY, 2023, 39 (12) : 5382 - 5390
  • [19] Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/smad signaling pathway
    Sun, Qingbo
    Hu, Jialiang
    Yu, Pengcheng
    Zhu, Zhaohao
    Yu, Ruihe
    Ge, Chuang
    Li, Chencheng
    Wu, Guiyue
    Lin, Bingjing
    Liu, Guangpan
    Liu, Meng
    Bian, Huan
    Xu, Hanmei
    Jia, Shaochang
    EXPERIMENTAL LUNG RESEARCH, 2019, 45 (5-6) : 123 - 134
  • [20] Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
    Y-L Chen
    X Zhang
    J Bai
    L Gai
    X-L Ye
    L Zhang
    Q Xu
    Y-X Zhang
    L Xu
    H-P Li
    X Ding
    Cell Death & Disease, 2013, 4 : e665 - e665